WISC Partners has been a long patient investor in Imbed. They were our first formal equity investors in 2014 and have since partnered with the founders on all the fronts of building a medical device business from early stages of scientific discovery. The General Partners and Executive Advisors are successful businessmen in their multiple industries. They were always ready to roll up their sleeves, open their network and work collaboratively in tackling the challenges of growing operations and raising growth capital. They passionately mentored me as a first-time scientist CEO and shared the depth of their experiences in execution – from managing board meetings to building out our executive team. Their empathy towards entrepreneurs along with clarity in the discipline of execution has allowed Imbed to navigate the many challenging times of a growing enterprise. Any entrepreneur can only wish to have such successful and supportive investors be part of their growth, and Imbed team was lucky to have found them early in our journey. I would highly recommend that entrepreneurs building scalable companies connect with WISC Partners to explore potential synergies.
Ankit Agarwal, PhD, CEO

Imbed Biosciences has developed wound-conforming, dissolvable microfilm dressings for use in tissue repair and regenerative medicine. Its first product, Microlyte Ag, already has FDA approval as a hydrogel dressing for use in the advanced wound care market.
For more information about Imbed Biosciences, please visit www.imbedbio.com.